ATE323164T1 - Oberfläche-exponierte proteine von chlamydia pneumoniae - Google Patents

Oberfläche-exponierte proteine von chlamydia pneumoniae

Info

Publication number
ATE323164T1
ATE323164T1 AT98928179T AT98928179T ATE323164T1 AT E323164 T1 ATE323164 T1 AT E323164T1 AT 98928179 T AT98928179 T AT 98928179T AT 98928179 T AT98928179 T AT 98928179T AT E323164 T1 ATE323164 T1 AT E323164T1
Authority
AT
Austria
Prior art keywords
kda
proteins
chlamydia pneumoniae
pneumoniae
relates
Prior art date
Application number
AT98928179T
Other languages
English (en)
Inventor
Svend Birkelund
Gunna Christiansen
Katrine Knudsen
Pedersen Anna-Sofie Hebsgaard
Per Mygind
Original Assignee
Loke Diagnostics Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loke Diagnostics Aps filed Critical Loke Diagnostics Aps
Application granted granted Critical
Publication of ATE323164T1 publication Critical patent/ATE323164T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT98928179T 1997-06-23 1998-06-19 Oberfläche-exponierte proteine von chlamydia pneumoniae ATE323164T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23

Publications (1)

Publication Number Publication Date
ATE323164T1 true ATE323164T1 (de) 2006-04-15

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928179T ATE323164T1 (de) 1997-06-23 1998-06-19 Oberfläche-exponierte proteine von chlamydia pneumoniae

Country Status (13)

Country Link
US (2) US7264941B1 (de)
EP (1) EP1007685B1 (de)
JP (1) JP4160640B2 (de)
CN (1) CN1249233C (de)
AT (1) ATE323164T1 (de)
AU (1) AU749382B2 (de)
BR (1) BR9810288A (de)
CA (1) CA2294651A1 (de)
DE (1) DE69834194T2 (de)
DK (1) DK1007685T3 (de)
ES (1) ES2264810T3 (de)
PT (1) PT1007685E (de)
WO (1) WO1998058953A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
EP1129202A2 (de) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia polypeptiden und entspechende dna fragmenten und anwendungen davon
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU1540500A (en) * 1998-12-01 2000-06-19 Aventis Pasteur Limited (chlamydia) antigens and corresponding dna fragments and uses thereof
EP1135501A1 (de) 1998-12-01 2001-09-26 Aventis Pasteur Limited Chlamydia antigene, dafür kodierende dna und deren verwendung
EP2172214A3 (de) * 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia-Antigene und entsprechende DNA-Fragmente sowie Verwendungen davon
JP4695763B2 (ja) 1999-05-03 2011-06-08 サノフィ、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
EP1220925B8 (de) 1999-09-20 2008-04-23 Sanofi Pasteur Limited Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
ATE440861T1 (de) * 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
CA3022947A1 (en) * 2016-05-04 2017-11-09 Children's Hospital & Research Center At Oakland Rapid extraction of nucleic acids from clinical samples for downstream applications
US20220221456A1 (en) * 2019-05-06 2022-07-14 Arocell Ab Respiratory infection detection and classification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
CN1249233C (zh) 2006-04-05
US20080226679A1 (en) 2008-09-18
AU749382B2 (en) 2002-06-27
JP4160640B2 (ja) 2008-10-01
ES2264810T3 (es) 2007-01-16
US7264941B1 (en) 2007-09-04
WO1998058953A2 (en) 1998-12-30
AU8011998A (en) 1999-01-04
EP1007685B1 (de) 2006-04-12
WO1998058953A3 (en) 1999-03-18
DK1007685T3 (da) 2006-08-14
DE69834194T2 (de) 2007-03-29
DE69834194D1 (de) 2006-05-24
CN1261403A (zh) 2000-07-26
CA2294651A1 (en) 1998-12-30
BR9810288A (pt) 2000-09-19
PT1007685E (pt) 2006-08-31
JP2002510970A (ja) 2002-04-09
EP1007685A2 (de) 2000-06-14

Similar Documents

Publication Publication Date Title
ATE323164T1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
RU2339646C2 (ru) Гибридная и тандемная экспрессия белков нейссерий
DE69431995D1 (de) Stabile Produkte des bakterientötenden/durchlässigkeiterhöhenden Proteins (PBI) und diese enthaltende Arzneimittelzusammensetzungen
WO2002090502A3 (en) Highly conserved proteins from gram-positive bacteria
EP1613345A4 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
ATE543513T1 (de) Anti-coronavirus impfstoff
EP0834568A3 (de) Speichel-bindendes Protein von Streptococcus pneumoniae
WO2004096856A3 (en) Secreted protein family
DE60126602D1 (de) Neue collectine
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
MX9805158A (es) Adn que codifica una proteina activadora de plasminogeno.
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
WO2004053117A3 (en) Serine protease
PT1651765E (pt) Novas sequências nucleotídicas e sequências de aminoácidos de photobacterium damselae, e sua utilização
AU2001239262A1 (en) Haemophilus influenza outer membrane protein and use thereof in vaccination
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
DK0811067T3 (da) Equin arteritisviruspeptider, antistoffer og deres anvendelse i en diagnostisk test
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2002050116A3 (en) Adhesion molecule protein
RU2000114245A (ru) Антигены нейссерий
WO2002046380A3 (en) Protein kinase
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
WO2002034901A3 (en) Protein kinase
WO2002008393A3 (en) Serine protease from yersinia enterocolitica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007685

Country of ref document: EP

REN Ceased due to non-payment of the annual fee